Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine gum to reduce sleep inertia after a night-time nap during sleep deprivation
ACTRN12617001486314Phase 4Recruiting
- Sponsor
- Siobhan Banks
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of caffeine (2 arms), sponsored by Siobhan Banks. Primary endpoints: Shift in melatonin onset and 3-minute Psychomotor Vigilance Task. Started Sep 2017; status: recruiting.
02
Drugs
caffeine
Beyond the preview
Go deeper on ACTRN12617001486314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001486314.